Biology and Marine Biology

106

Arthur R. Frampton Jr., H. Uchida, J. von Einem, W. F. Goins, P. Grandi, J. B. Cohen, N.

Osterrieder, J. C. Glorioso. Equine Herpesvirus Type 1 (EHV-1) utilizes microtubules, dynein, and

ROCK1 to productively infect cells. (2010) Veterinary Microbiology 141: 12 -21.

Brian M. Kurtz, L. B. Singletary, S. D. Kelly, and Arthur R. Frampton Jr. Equus caballus MHC

class I is an entry receptor for equine herpesvirus type 1 (EHV-1). (2010) Journal of Virology 84:

9027-9034.

Michael J. Courchesne, M. C. White, B. A. Stanfield, and Arthur R. Frampton Jr. Equine

herpesvirus type 1 (EHV-1) mediated oncolysis of human glioblastoma multiforme cells. (2012)

Journal of Virology 86: 2882-2886.

Julia Kydd, J. Slater, N. Osterrieder, P. Lunn, D. Antczak, W. Azab, U. Balasuriya, C. Barnett, M.

Brosnahan, C. Cook, A. Damiani, D. Elton, A. R. Frampton Jr., J. Gilkerson, L. Goehring, D.

Horohov, L. Maxwell, J. Minke, P. Morley, H. Nauwynck, R. Newton, G. Perkins, N. Pusterla, G.

Soboll-Hussey, J. Traub-Dargatz, H. Townsend, G. Van de Walle, B. Wagner.Third International

Havemeyer Workshop on Equine Herpesvirus Type 1 (EHV-1). (2012) Equine Veterinary Journal.

Vol. 44:5, 513-517.

Maria C. White and Arthur R. Frampton Jr. The histone deacetylase inhibitor valproic acid

enhances equine herpesvirus type 1 (EHV-1) mediated oncolysis of human glioma cells. (2013)

Cancer Gene Therapy, 20 , 88-93.

Walid Azab, R. Harman, D. Miller, R. Tallmadge, A.R. Frampton Jr., D.F. Antczak, and N.

Osterrieder. Equine herpesvirus type 4 (EHV-4) uses a restricted set of equine major

histocompatibility complex class I proteins as entry receptors. (2014) Journal of General Virology.

Vol. 95, 1554-1563.

Presentations and Abstracts:

Arthur R. Frampton Jr., P.M. Smith, Y. Zhang, T. Matsumura, N. Osterrieder, and D.J.

O’Callaghan. Oral presentation. “Pathogenesis of EHV-1 Glycoprotein I and E Recombinants in a

Murine Model. 21st Annual Meeting of the American Society for Virology, Lexington, Kentucky,

July 20-24, 2002.

H. Kwon, Q. Bai, W. Shah, K. Felmet, L. Berne, A.R. Frampton Jr., W.F. Goins, J.B. Cohen, J.C.

Glorioso. “Targeting Herpes Simplex Virus (HSV) Infection.” American Society for Microbiology,

Gene Therapy: The Next Five Years, Banff, Alberta, Canada, February 26-March 1, 2003.

H. Kwon, Q. Bai, W. Shah, K. Felmet, L. Byrne, A.R. Frampton Jr., W.F. Goins, J.B. Cohen, J.C.

Glorioso. “Targeting Herpes Simplex Virus (HSV) Infection Using Soluble Receptor/Adapter

Molecules.” The 6th Annual Meeting of The American Society of Gene Therapy, Washington, D.C.,

June 4-8, 2003.

H. Kwon, Q. Bai, K. Felmet, M. Tsvitov, A.R. Frampton Jr., W.F. Goins, J.B. Cohen, and J.C.

Glorioso. “Targeting HSV Infection Using Soluble Receptor/Adapter Molecules.” 28th International

Herpesvirus Workshop, Madison, Wisconsin, July 26-31, 2003.